<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Renzi S</submitter><pubmed_abstract>Lipid nanoparticles (LNPs) play a crucial role in addressing genetic disorders, and cancer, and combating pandemics such as COVID-19 and its variants. Yet, the ability of LNPs to effectively encapsulate large-size DNA molecules remains elusive. This is a significant limitation, as the successful delivery of large-size DNA holds immense potential for gene therapy. To address this gap, the present study focuses on the design of PEGylated LNPs, incorporating large-sized DNA, departing from traditional RNA and ionizable lipids. The resultant LNPs demonstrate a unique particle morphology. These particles were further engineered with a DNA coating and plasma proteins. This multicomponent bionanoconstruct exhibits enhanced transfection efficiency and safety in controlled laboratory settings and i</pubmed_abstract><journal>Nature communications</journal><pagination>9119</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11496629</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene delivery.</pubmed_title><pmcid>PMC11496629</pmcid><pubmed_authors>Renzi S</pubmed_authors><pubmed_authors>Pozzi D</pubmed_authors><pubmed_authors>Pesce L</pubmed_authors><pubmed_authors>Cardarelli F</pubmed_authors><pubmed_authors>Mancusi A</pubmed_authors><pubmed_authors>Digiacomo L</pubmed_authors><pubmed_authors>Rossi M</pubmed_authors><pubmed_authors>De Lorenzi V</pubmed_authors><pubmed_authors>Montone CM</pubmed_authors><pubmed_authors>Mura F</pubmed_authors><pubmed_authors>Natiello B</pubmed_authors><pubmed_authors>Amenitsch H</pubmed_authors><pubmed_authors>Laura Capriotti A</pubmed_authors><pubmed_authors>Lagana A</pubmed_authors><pubmed_authors>Checquolo S</pubmed_authors><pubmed_authors>Quagliarini E</pubmed_authors><pubmed_authors>Parisi G</pubmed_authors><pubmed_authors>Pignataro MG</pubmed_authors><pubmed_authors>Zingoni A</pubmed_authors><pubmed_authors>Canettieri G</pubmed_authors><pubmed_authors>Giuli MV</pubmed_authors><pubmed_authors>Loconte L</pubmed_authors><pubmed_authors>Nicoletti C</pubmed_authors><pubmed_authors>Vulpis E</pubmed_authors><pubmed_authors>Di Magno L</pubmed_authors><pubmed_authors>Ghignoli S</pubmed_authors><pubmed_authors>Caracciolo G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene delivery.</name><description>Lipid nanoparticles (LNPs) play a crucial role in addressing genetic disorders, and cancer, and combating pandemics such as COVID-19 and its variants. Yet, the ability of LNPs to effectively encapsulate large-size DNA molecules remains elusive. This is a significant limitation, as the successful delivery of large-size DNA holds immense potential for gene therapy. To address this gap, the present study focuses on the design of PEGylated LNPs, incorporating large-sized DNA, departing from traditional RNA and ionizable lipids. The resultant LNPs demonstrate a unique particle morphology. These particles were further engineered with a DNA coating and plasma proteins. This multicomponent bionanoconstruct exhibits enhanced transfection efficiency and safety in controlled laboratory settings and i</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-07-15T08:11:58.534Z</modification><creation>2025-04-06T22:45:40.121Z</creation></dates><accession>S-EPMC11496629</accession><cross_references><pubmed>39438484</pubmed><doi>10.1038/s41467-024-53569-8</doi></cross_references></HashMap>